Clinical Trials Directory

Trials / Unknown

UnknownNCT02868905

Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women

Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women - Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare average methylation of epigenetic markers on genomic DNA and some genes (APP, BACE, LRP, SorL1) involved in cerebral amyloid homeostasis: * Of obese young adults and healthy young adults * Of obese young adults and individuals affected by Alzheimer's disease (AD) having been obese at young adult age (\<50 years old) or individuals affected by Alzheimer's disease (AD) having never been obese. The secondary purpose is to determine if there is an association between the frequency of these epigenetic markers and elements associated to the metabolic syndrome (lipidic and glycemic analysis, leptinemia, inflammation markers) and clinical ones (visceral fat mass, body mass index) in young adults.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sample

Timeline

Start date
2016-09-01
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2016-08-16
Last updated
2016-08-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02868905. Inclusion in this directory is not an endorsement.

Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women (NCT02868905) · Clinical Trials Directory